Our results showed that knocking down KIF4A expression suppresses FOXM1 mediated HCC cell proliferation and tumor growth, suggesting that FOXM1–KIF4A axis may be a potential therapeutic target for HCC treatment. This evidence concerns the gene FOXM1 and hepatocellular carcinoma.